Medical University of Luebeck, MD 2002
Cornell University, PhD 2008
Massachusetts Institute of Technology, Postdoctoral training, 2008-2012
The main goal of our laboratory is to explore the fast-developing and highly interdisciplinary field of immunobioengineering. Using next-generation immunomodulatory synthetic materials, we are developing new approaches to therapeutically boost the body's natural ability to fight cancer. Our primary research focus is the design of stimulatory biomaterial devices, drug delivery systems and bioactive substances to enhance adoptive immunotherapy for cancer.
These tools offer a powerful complement to traditional genetic engineering strategies for enhancing the function of tumor-reactive immune cells, and might ultimately allow for widespread application of adoptive immunotherapy in the clinic.